Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy : PAIN

Journal Logo

Research Paper

Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy

Rice, Andrew S.C.a; Dworkin, Robert H.b; Finnerup, Nanna B.c; Attal, Nadined,e; Anand, Praveenf; Freeman, Royg; Piaia, Alessandroh; Callegari, Francescai; Doerr, Christiej; Mondal, Subhayank; Narayanan, Nishak; Ecochard, Laurenti; Flossbach, Yaninai; Pandhi, Shalooi,*

Author Information
PAIN 162(10):p 2578-2589, October 2021. | DOI: 10.1097/j.pain.0000000000002252

© 2021 International Association for the Study of Pain

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid